| dc.date.accessioned | 2016-01-24T05:40:52Z | |
| dc.date.available | 2016-01-24T05:40:52Z | |
| dc.date.issued | 2016-01-24 | |
| dc.identifier.uri | http://hdl.handle.net/123456789/3254 | |
| dc.description.abstract | Large global biopharmaceutical manufacturers producing biogenerics like erythropotien, insulin, statins, Granulocyte Colony Stimulating Factor (GCSF), interferon, growth hormones etc. are now looking at India as a packaging base. They import bulks in large quantities from their plants in Europe, Canada and China etc. and employ the services of Indian packaging plants to package these products in dispensable units (vials, prefilled syringes,etc.). | en_US |
| dc.language.iso | en | en_US |
| dc.publisher | Gujarat State Biotechnology Mission | en_US |
| dc.subject | Emerging Technologies, Project profile | en_US |
| dc.title | Biopharmaceuticals Packaging Unit | en_US |
| dc.type | Project Profiles | en_US |